Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
7.07
-0.27 (-3.68%)
At close: Jun 2, 2025, 4:00 PM
7.10
+0.03 (0.42%)
After-hours: Jun 2, 2025, 7:03 PM EDT
Novavax Employees
Novavax had 952 employees as of December 31, 2024. The number of employees decreased by 591 or -38.30% compared to the previous year.
Employees
952
Change (1Y)
-591
Growth (1Y)
-38.30%
Revenue / Employee
$1,318,237
Profits / Employee
$502,833
Market Cap
1.15B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
NVAX News
- 4 days ago - Novavax to Participate in Upcoming Investor Conferences - PRNewsWire
- 12 days ago - Novavax: Nuvaxovid FDA Approval Unlocks Several Bullish Stimuli - Seeking Alpha
- 13 days ago - Healthy Returns: Novavax scores narrower Covid vaccine approval after delay - CNBC
- 14 days ago - Top Stock Movers Now: Tesla, AutoZone, Novavax, and More - Investopedia
- 14 days ago - Novavax Stock Rockets. FDA Finally Had Good News for the Covid-19 Vaccine Maker. - Barrons
- 14 days ago - Novavax shares jump after long-awaited FDA approval of its COVID-19 vaccine - Reuters
- 14 days ago - U.S. FDA Approves BLA for Novavax's COVID-19 Vaccine - PRNewsWire
- 15 days ago - FDA approves Novavax COVID vaccine with new conditions - Reuters